Citius pharmaceuticals to present at upcoming october investor conferences

Cranford, n.j., oct. 6, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products, and stem cell therapies, today announced that it will present at two investor conferences during the month of october 2021.
CTXR Ratings Summary
CTXR Quant Ranking